VistaGen Therapeutics, Inc.·4

Jan 3, 4:11 PM ET

DOTSON JERROLD DUANE 4

4 · VistaGen Therapeutics, Inc. · Filed Jan 3, 2023

Insider Transaction Report

Form 4
Period: 2022-12-30
Transactions
  • Award

    Common Stock

    2022-12-30$0.09/sh+5,000$438105,111 total
Footnotes (1)
  • [F1]Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan ("ESPP").

Documents

1 file
  • 4
    form4-01032023_090100.xmlPrimary